On Sept 6, Don Agro’s wholly-owned subsidiary, JSC Tetra, signed agreements with the sellers Khvicha Akubardia and Aleksander Sviridov. Akubardia owns about 70.01% of the shares in 812 Capital and 10% of the shares in CIMT. Sviridov owns about 20% of the shares in 812 Capital and 1.5% of the shares in CIMT.
Don Agro International has proposed to acquire a 99.99% stake in 812 Capital LLC and 11.5% of the shares in Centre for Innovative Medical Technologies (CIMT) for 3.04 billion Russian rubles ($43.7 million).
Both 812 Capital and the Centre for Innovative Medical Technologies are also known as the “target group”. 812 Capital is the holding company for the group, a federal network of oncology clinics operating under the Euroonco brand in the Russian cities of Moscow, Saint Petersburg, Nizhny Novgorod and Krasnodar. It provides a full range of cancer diagnostics and treatment services including surgical interventions of any complexity and all types of antitumor and palliative treatment.
